Sensitivity a hundred times worse? Understand the true advantages of Caspase-3/7 luminescence assay in one article

Author: Senior Product Manager of UA Views：16

Apoptosis is a genetically regulated programmed cell death that plays a central role in development, immune homeostasis, tissue renewal, and tumorigenesis. The caspase family (cysteine-aspartic proteases) serves as key executioners of apoptosis: initiator caspases (e.g., Caspase-8/9) sense death signals and subsequently activate executioner Caspase-3/7 through a cascade. These effector caspases cleave substrates such as PARP and cytoskeletal proteins, ultimately leading to cellular disintegration.

Recent Advances
Product Information

Recent Advances

100-Fold Difference in Sensitivity? Understanding the True Advantages of Caspase-3/7 Luminescence Assay

Apoptosis is a genetically regulated programmed cell death that plays a central role in development, immune homeostasis, tissue renewal, and tumorigenesis. The caspase family is the key executor of apoptosis: initiator caspases (e.g., Caspase-8/9) sense death signals and cascade-activate executioner Caspase-3/7, which cleaves substrates such as PARP and cytoskeletal proteins, ultimately leading to cell disintegration.

Caspase-3/7 activity is one of the gold standard indicators for measuring apoptosis. In drug development, antitumor efficacy evaluation, and apoptosis mechanism research, a sensitive, high-throughput, and quantifiable detection method is required—luminescence assays are currently one of the most mainstream choices: they use a "luminescent substrate + luciferase" core to achieve "add-mix-read" one-step detection, with high sensitivity, low background, and no washing required.

Detection Principle

The core of the luminescence assay is a proluminescent substrate:

The entire reaction can be summarized in three steps:

1. Cleavage: Activated Caspase-3/7 in apoptotic cells cleaves the substrate;

2. Release: The cleaved substrate releases free aminoluciferin;

3. Luminescence: The luciferase in the reagent catalyzes aminoluciferin in the presence of ATP and O₂ to produce photons, generating a stable "glow-type" luminescent signal.

The luminescence intensity is proportional to Caspase-3/7 activity, which in turn is proportional to the degree of apoptosis, enabling quantitative detection of apoptosis. The linear range of this signal spans approximately four orders of magnitude of enzyme concentration, and it produces a stable glow-type luminescence, eliminating the need for "flash reading."

Comparison of Detection Methods

There are numerous apoptosis detection methods, with core differences lying in the dimensions they measure: luminescence assays measure "enzyme activity," Western blot measures "protein quantity," Annexin V/PI measures "membrane markers," and TUNEL measures "DNA fragmentation."

Comparison of common apoptosis detection methods:

Method	Detection Target	Sensitivity	Throughput	Operational Features
Luminescence Caspase-3/7	Executioner caspase enzyme activity	Extremely high	High	Homogeneous single reagent, no washing; stable glow-type signal
Fluorescence Caspase-3/7	Caspase enzyme activity	High	Medium–High	Some require washing/media change; compatible with microscopy or flow cytometry
Colorimetric Caspase-3/7	Caspase enzyme activity (405 nm absorbance)	Low	Medium	Conventional plate readers can read; low cost
Western blot	Activated protein expression	Medium (semi-quantitative)	Low	Requires protein extraction and electrophoresis; high specificity
Annexin V / PI	Phosphatidylserine externalization + membrane integrity	Medium	Medium	Requires live cells/single-cell suspension; single-cell quantification, distinguishes early/late stages
TUNEL	DNA fragmentation ends	Medium	Low–Medium	Tissue sections/fixed cells; microscopy for localization

Selection advice: For high-throughput screening and drug dose-response studies, luminescence assays are the first choice. For single-cell localization or morphological evidence, combine with Annexin V/PI flow cytometry or fluorescence imaging. For mechanism validation, use Western blot to confirm cleaved Caspase-3. For tissue sections or fixed samples, use TUNEL. Multi-parameter assays (e.g., "luminescence apoptosis + viability + cytotoxicity" trio) provide a more comprehensive cell health profile.

Main Applications

• Antitumor drug efficacy evaluation: Measuring dose-response curves of candidate compounds inducing apoptosis, e.g., proteasome inhibitors like bortezomib can dose-dependently activate Caspase-3/7;

• High-throughput screening (HTS) of compound libraries: The homogeneous, no-wash format is naturally suited for 96/384/1536-well plates and can be integrated with automated workstations for large-scale screening;

• Apoptotic pathway mechanism research: Combine with initiator caspases or pan-caspase inhibitors to validate pathway cascades and specificity;

• Multiplex assays: Sequential detection in the same well with cell viability (UA-Glo® Luminescent Cell Viability Assay) or cytotoxicity (e.g., UA-Glo® LDH Luminescence Cytotoxicity Assay) to distinguish "proliferation inhibition—membrane damage—caspase-dependent apoptosis" outcomes;

• 3D culture and in vivo models: Enhanced lysis formulations for spheroids/organoids/microtissues (3D version kits) are also mature.

Conclusion

The Caspase-3/7 luminescence assay directly converts apoptotic signals into stable luminescent output, achieving the best balance of sensitivity, throughput, and convenience. It is both a primary tool for drug screening and high-throughput evaluation and a fundamental method for apoptosis mechanism research.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next